Clinical trial NCT01660737: Observational Study With PASCALLERG ® in Patients With Hay Fever
Official title: Observational Study With PASCALLERG ® in Patients With Hay Fever
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hay Fever
Keywords: Hay fever
Pascallerg
Lead sponsor: Pascoe Pharmazeutische Praeparate GmbH
Sponsor class: INDUSTRY
First posted: 2012-08-09
Enrollment: 123
Sex: ALL
Minimum age (years): 1
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: patients from natural practioners and doctors from Germany

Brief summary: The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.

Detailed description: There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.

Eligibility criteria: Inclusion Criteria:

* hay fever

Exclusion Criteria:

* Lactose intolerance and / or
* Chromium hypersensitivity

Primary outcomes:
measure: Efficacy of Pascallerg
timeFrame: appr. 4 weeks after baseline (after appr. 4 weeks of treatment)
measure: Tolerability of Pascallerg
timeFrame: app. 4 weeks after baseline (treatment app. for 4 weeks)
Secondary outcomes:
measure: Numerical Rating Scale Well Beeing (Pre- Post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Dry Eyes (Pre- Post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Itching Eyes (Pre- Post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Burning Eyes (Pre-post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Bronchial Complaints (Pre-post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Sneezing (Pre-post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Rhinitis (Pre-post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symtom Fatigue / Tiredness
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Headache (Pre-post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
measure: Change of Symptom Tearing Eyes (Pre-post)
timeFrame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Other outcomes:
Locations:
city: Gießen
country: Germany
facility: Jennifer Lebert
Study officials:
References:
citation: Trompetter I, Lebert J, Weiss G. Homeopathic complex remedy in the treatment of allergic rhinitis: results of a prospective, multicenter observational study. Forsch Komplementmed. 2015;22(1):18-23. doi: 10.1159/000375244. Epub 2015 Feb 9.